LONDON (Alliance News) - The International Biotechnology Trust PLC Thursday said it has upped the valuation of its interest in Affinium Pharmaceuticals, an unquoted portfolio company, after it was sold to Debiopharm Group.
In a statement, the trust said it upped the valuation of its interest in the company to GBP1.8 million from GBP800,000 "to reflect the deal".
It said its net asset value, to be published Friday, will benefit to the tune of 1.76 pence because of the deal.
The trust's shares were Thursday quoted at 304.45 pence, down 1.55 pence, or 0.5%.
By Samuel Agini; samagini@alliancenews.com; @samuelagini
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Int.biotech. (IBT)